Skip to main content
. 2022 Dec 9;19(24):16556. doi: 10.3390/ijerph192416556

Table 6.

Factors associated with multi-drug resistance in patients with urinary tract infections with culture-positive samples tested at MDS Lancet Laboratories, Ghana, from 2017 to 2021.

Factors Total
n 1
MDR
n (%) 2
PR (95% CI) aPR (95% CI) p-Value
Age in years
<15 1474 854 (57.9) Ref Ref
15–44 7771 4595 (59.1) 1.01 (0.97–1.06) 1.05 (0.99–1.09) 0.06
45–64 4539 3020 (66.5) 1.14 (1.09–1.20) 1.14 (1.08–1.19) <0.001
≥5 6040 4207 (69.6) 1.20 (1.14–1.25) 1.16 (1.11–1.22) <0.001
Sex
Male 5484 3989 (72.7) 1.20 (1.17–1.22) 1.13 (1.11–1.16) <0.001
Female 14,505 8783 (60.5) Ref Ref
Specimen location 3
Accra 12,702 7931 (62.4) Ref Ref
Ashanti 4266 2722 (63.8) 1.02 (0.99–1.05) 1.04 (1.01–1.07) 0.002
Others 3042 2131 (63.8) 1.12 (1.09–1.15) 1.09 (1.07–1.13) <0.001
Antimicrobial substance in urine
Present 1986 1742 (87.1) 1.43 (1.40–1.46) 1.40 (1.37–1.43) <0.001
Absent 18,007 11,030 (61.2) Ref Ref

1 Missing values in age (186), sex (21) and antimicrobial substance in urine (17) dropped from analysis; 2 Row percentages; 3 Specimen locations are the regions from where the samples were collected. Samples from regions outside greater Accra were well-packaged and transported in temperature-regulated specimen bags; MDR—Multi-drug resistance; PR—prevalence ratio; CI—confidence interval; aPR—adjusted prevalence ratio.